AstraZeneca Says Its COVID-19 Vaccine Is Safe, Despite Reports of Deadly Clots
The AstraZeneca vaccine, developed with researchers from Oxford University, has been heavily used in Britain
Ebola Outbreak Likely Triggered by Survivor
Investigation suggests survivor carried the virus for at least five years and then transmitted it via semen to a sex partner
Physician’s Briefing Weekly Coronavirus Roundup
Over Half Have Symptoms of Major Depressive Disorder After COVID-19
Presence of headache and greater overall severity linked to increased odds of moderate or greater depression symptoms
Novavax COVID-19 Vaccine Highly Effective in Clinical Trials
Company will present the data to regulatory agencies worldwide, including the FDA
Pfizer COVID-19 Vaccine 97 Percent Effective Against Symptomatic Disease
Analysis of data from Israel's vaccination campaign also showed vaccine to be 94 percent effective against asymptomatic disease
Women Show Faster Cognitive Decline Than Men
Declines in global cognition and executive function significantly faster for women, despite higher baseline performance
Patient-Provider Gender Concordance Affects Patient Heart Outcomes
American College of Cardiology workgroup recommends improving gender diversity in the workforce, research, and medical education
Early Immunologic Biomarker Predicts Renal Allograft Outcomes
Ratio of IL-10/TNFα produced by T1B three months after renal transplantation predicts clinical, subclinical rejection during first year
Immune Response Strong After One Dose in COVID-19-Seropositive Vaccinees
Vaccinees with preexisting immunity have antibody titers 10 to 45 times higher than those without preexisting immunity
